Nebulisation of alpha-tocopherol in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005
Pharmacological activities of roflumilast N-oxide, dexamethasone and formoterol in human neutrophils from healthy non-smokers and COPD patients Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014
Effect of indacaterol maleate on dynamic lung hyperinflation in patients with COPD Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
Pro?ling of systemic in?ammation and glutathione metabolism in COPD Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020
The pharmacokinetics of inhaled NVA237 in COPD patients Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
Pharmacokinetics of roflumilast and its active metabolite roflumilast N-oxide are not influenced by erythromycin Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004
The pharmacodynamics of GSK961081 in patients with COPD Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Reduction of exacerbations with salmeterol/fluticasone combination 50/500mcg bd in the treatment of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 241s Year: 2002
Lipid peroxidation and antioxidative enzymes in patients with COPD: relationship to pulmonary hyperinflation Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Population pharmacokinetics of nebulized arformoterol in subjects with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 427s Year: 2006
Population pharmacokinetics and pharmacodynamics of GSK961081 (MABA) in patients with moderate to severe COPD Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Rapid onset bronchodilation with formoterol or salbutamol in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 514s Year: 2001
The ATTAIN study: Bronchodilatory effect of aclidinium bromide in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
COPD Source: Eur Respir Monogr 2017; 77: 147-166 Year: 2017
COPD Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017
COPD Source: ERS Lung Science Conference 2016 Year: 2016
COVID-19 and COPD Source: Eur Respir J, 56 (2) 2002108; 10.1183/13993003.02108-2020 Year: 2020
COPD Source: Eur Respir Monogr 2017; 77: 13-24 Year: 2017